Researchers Reformulate HIV Vaccine, Ready To Begin Clinical Trial In South Africa New HIV trial will begin in South Africa, in the attempt to diminish and even eradicate this disease. The subjects taking part in this trial will be monitored for two years after being administered the medication. by Livia Rusu